The risk of residual molecular and cytogenetic disease in patients with philadelphia-chromosome positive first chronic phase chronic myelogenous leukemia is reduced after transplantation of allogeneic peripheral blood stem cells compared with bone marrow: A. Elmaagacli, D. Beelen, B. Opalka, et al. Blood 94:384–389, 1999

✍ Scribed by Christopher D. Hillyer

• Book ID: 114268073
• Publisher: Elsevier Science
• Year: 2000
• Tongue: English
• Weight: 116 KB
• Volume: 14
• Category: Article
• ISSN: 1532-9496
• DOI: 10.1016/s0887-7963(00)80119-4